Pharmacotherapeutic approaches to treating postpartum depression: a focus on GABA A receptor positive allosteric modulators

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research focuses on the efficacy and mechanisms of GABA receptor positive allosteric modulators in treating postpartum depression (PPD).
Review of clinical, observational, and preclinical studies on neuroactive steroids and GABAergic function.
Analysis of clinical trial data for brexanolone and zuranolone.
Discussion of GABAergic plasticity and stress-axis regulation in PPD.
Brexanolone and zuranolone demonstrate rapid onset of antidepressant effects with sustained benefits.
GABAergic modulation shows promise in addressing dysregulation associated with postpartum depression.
Evidence supports that these therapeutic agents may have broader applications in related psychiatric disorders.

Demonstrates rapid antidepressant effects of GABA receptor modulators in postpartum depression, indicating a new treatment avenue.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Stewart et al. (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share